These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 23822889

  • 21. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.
    Zappala CJ, Latsi PI, Nicholson AG, Colby TV, Cramer D, Renzoni EA, Hansell DM, du Bois RM, Wells AU.
    Eur Respir J; 2010 Apr; 35(4):830-6. PubMed ID: 19840957
    [Abstract] [Full Text] [Related]

  • 22. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.
    Prasse A, Probst C, Bargagli E, Zissel G, Toews GB, Flaherty KR, Olschewski M, Rottoli P, Müller-Quernheim J.
    Am J Respir Crit Care Med; 2009 Apr 15; 179(8):717-23. PubMed ID: 19179488
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [A comparison of clinical features between patients with idiopathic pulmonary fibrosis combined with emphysema and without emphysema].
    Ma JW, Li ZH, Xu H, Wang HJ, Kang J, Yu RJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar 15; 36(3):173-6. PubMed ID: 23856138
    [Abstract] [Full Text] [Related]

  • 25. Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects.
    Lee SH, Shim HS, Cho SH, Kim SY, Lee SK, Son JY, Jung JY, Kim EY, Lim JE, Lee KJ, Park BH, Kang YA, Kim YS, Kim SK, Chang J, Park MS.
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct 15; 28(2):102-12. PubMed ID: 22117501
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis.
    Malli F, Bardaka F, Tsilioni I, Karetsi E, Gourgoulianis KI, Daniil Z.
    Food Chem Toxicol; 2013 Nov 15; 61():160-3. PubMed ID: 23702326
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
    Yuan YD, Zhao MX, Yu J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov 15; 34(11):841-5. PubMed ID: 22333472
    [Abstract] [Full Text] [Related]

  • 32. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J.
    J Neurosurg; 2016 Jan 15; 124(1):122-8. PubMed ID: 26230475
    [Abstract] [Full Text] [Related]

  • 33. Association of early suspected acute exacerbations of idiopathic pulmonary fibrosis with subsequent clinical outcomes and healthcare resource utilization.
    Yu YF, Macaulay DS, Reichmann WM, Wu EQ, Nathan SD.
    Respir Med; 2015 Dec 15; 109(12):1582-8. PubMed ID: 26607877
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C.
    Int J Cancer; 2013 Jan 01; 132(1):116-27. PubMed ID: 22674182
    [Abstract] [Full Text] [Related]

  • 36. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis.
    Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O'Byrne PM, Strieter RM, Kolb M.
    Am J Respir Crit Care Med; 2009 Apr 01; 179(7):588-94. PubMed ID: 19151190
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease.
    Miyaaki H, Ichikawa T, Kamo Y, Taura N, Honda T, Shibata H, Milazzo M, Fornari F, Gramantieri L, Bolondi L, Nakao K.
    Liver Int; 2014 Aug 01; 34(7):e302-7. PubMed ID: 24313922
    [Abstract] [Full Text] [Related]

  • 39. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference.
    du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, King TE, Lancaster L, Noble PW, Sahn SA, Thomeer M, Valeyre D, Wells AU.
    Am J Respir Crit Care Med; 2011 Dec 15; 184(12):1382-9. PubMed ID: 21940789
    [Abstract] [Full Text] [Related]

  • 40. Analysis of gene expression in canine idiopathic pulmonary fibrosis.
    Krafft E, Laurila HP, Peters IR, Bureau F, Peeters D, Day MJ, Rajamäki MM, Clercx C.
    Vet J; 2013 Nov 15; 198(2):479-86. PubMed ID: 24120450
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.